Unknown

Dataset Information

0

Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry.


ABSTRACT:

Introduction

To compare the efficacy of abatacept and tumor necrosis factor inhibitor (TNFi) in patients with anti-citrullinated protein antibody (ACPA)-positive rheumatoid arthritis (RA) and identify those who benefit most from abatacept over TNFi.

Methods

This observational study identified RA patients who were ACPA-positive and initiated abatacept or TNFi from the Korean College of Rheumatology Biologics and Targeted therapy registry. Propensity score (PS) matching was performed to balance baseline confounding in abatacept- or TNFi-treated patients. The major endpoints were changes in Clinical Disease Activity Index (CDAI) and achievement of CDAI remission/low disease activity after 1 year of treatment. Subgroup analysis was mainly performed stratified by prior biologics use.

Results

A total of 291 PS-matched, ACPA-positive RA patients who initiated abatacept (n = 97) and TNFi (n = 194) were included. From baseline CDAI scores of 26.52 in the abatacept group and 26.38 in the TNFi group, the mean changes after 1 year were - 16.78 and - 13.61, respectively (difference - 3.17, p = 0.020). The proportion of patients achieving CDAI remission/low disease activity was 68.0% with abatacept and 52.6% with TNFi (p = 0.013). In the subgroup analysis, patients that were biologics-naïve had better improvement in CDAI after treatment with abatacept than TNFi (difference - 3.35, p = 0.021).

Conclusions

This real-world study suggests that abatacept may have better clinical response compared to TNFi in patients with established ACPA-positive RA, especially in those that were biologics-naïve.

SUBMITTER: Kim MJ 

PROVIDER: S-EPMC9314478 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8133894 | biostudies-literature
| S-EPMC6513934 | biostudies-literature
| S-EPMC6191131 | biostudies-literature
| S-EPMC6985057 | biostudies-literature
| S-EPMC6586539 | biostudies-literature
| S-EPMC6117139 | biostudies-literature
2021-08-23 | GSE172188 | GEO
| S-EPMC10834537 | biostudies-literature
| S-EPMC6033104 | biostudies-literature
| S-EPMC3969965 | biostudies-other